Susquehanna International Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
16,635
+7,213
+77% +$504K ﹤0.01% 7476
2025
Q4
$771K Buy
+9,422
New +$704K ﹤0.01% 7780
2025
Q3
Sell
-52,334
Closed -$2.58M 13844
2025
Q2
$2.12M Sell
52,334
-8,523
-14% -$384K ﹤0.01% 5660
2025
Q1
$3.13M Sell
60,857
-3,266
-5% -$161K ﹤0.01% 4571
2024
Q4
$3.55M Buy
64,123
+51,669
+415% +$2.35M ﹤0.01% 4149
2024
Q3
$410K Buy
+12,454
New +$350K ﹤0.01% 8948
2024
Q2
Sell
-60,994
Closed -$2.05M 13214
2024
Q1
$2.22M Sell
60,994
-30,429
-33% -$895K ﹤0.01% 5083
2023
Q4
$1.85M Buy
+91,423
New +$1.53M ﹤0.01% 5533
2023
Q3
Sell
-32,435
Closed -$574K 12954
2023
Q2
$586K Buy
+32,435
New +$516K ﹤0.01% 7938
2022
Q4
Sell
-14,257
Closed -$244K 13640
2022
Q3
$244K Buy
+14,257
New +$226K ﹤0.01% 10334

Other funds holding TARS